Lisata Therapeutics, Inc. (LSTA)
LSTA Stock Price Chart
Explore Lisata Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze LSTA price movements and trends.
LSTA Company Profile
Discover essential business fundamentals and corporate details for Lisata Therapeutics, Inc. (LSTA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Mar 1999
Employees
26.00
Website
https://www.lisata.comCEO
David J. Mazzo
Description
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
LSTA Financial Timeline
Browse a chronological timeline of Lisata Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
Earnings released on 11 May 2026
EPS came in at -$0.50 .
Earnings released on 12 Mar 2026
EPS came in at -$0.33 surpassing the estimated -$0.51 by +35.29%, while revenue for the quarter reached $100.00k , meeting expectations.
Earnings released on 6 Nov 2025
EPS came in at -$0.49 surpassing the estimated -$0.54 by +9.26%.
Earnings released on 7 Aug 2025
EPS came in at -$0.54 surpassing the estimated -$0.65 by +16.92%, while revenue for the quarter reached $70.00k .
Earnings released on 8 May 2025
EPS came in at -$0.55 falling short of the estimated -$0.53 by -3.77%.
Earnings released on 27 Feb 2025
EPS came in at -$0.55 surpassing the estimated -$0.76 by +27.63%, while revenue for the quarter reached $1.00m .
Earnings released on 12 Nov 2024
EPS came in at -$0.59 surpassing the estimated -$0.75 by +21.33%.
Earnings released on 12 Aug 2024
EPS came in at -$0.61 surpassing the estimated -$0.75 by +18.67%.
Earnings released on 9 May 2024
EPS came in at -$0.65 surpassing the estimated -$0.73 by +10.96%.
Earnings released on 29 Feb 2024
EPS came in at -$0.66 surpassing the estimated -$0.86 by +23.26%.
Earnings released on 2 Nov 2023
EPS came in at -$0.65 surpassing the estimated -$0.93 by +30.11%.
Earnings released on 14 Aug 2023
EPS came in at -$0.50 surpassing the estimated -$0.70 by +28.57%.
Earnings released on 9 May 2023
EPS came in at -$0.77 surpassing the estimated -$0.81 by +4.94%.
Earnings released on 30 Mar 2023
EPS came in at -$0.76 surpassing the estimated -$0.96 by +20.83%, while revenue for the quarter reached $121.37m .
Earnings released on 10 Nov 2022
EPS came in at -$1.47 falling short of the estimated -$0.90 by -63.33%.
Stock split effective on 15 Sept 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 4 Aug 2022
EPS came in at -$1.65 falling short of the estimated -$1.45 by -13.79%.
Earnings released on 5 May 2022
EPS came in at -$1.05 surpassing the estimated -$1.45 by +27.59%.
Earnings released on 22 Mar 2022
EPS came in at -$1.65 surpassing the estimated -$2.17 by +23.96%.
Earnings released on 4 Nov 2021
EPS came in at -$1.80 surpassing the estimated -$2.25 by +20.00%.
Earnings released on 5 Aug 2021
EPS came in at -$1.50 surpassing the estimated -$2.17 by +30.88%.
LSTA Stock Performance
Access detailed LSTA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
